Identification of H5N1-specific T-Cell responses in a high-risk cohort in Vietnam indicates the existence of potential asymptomatic infections

Journal of Infectious Diseases

Volumn 205, Issue 1, 2012, Pages 20-27

  Powell, Timothy J ^a   Fox, Annette ^b   Peng, Yanchun ^a   Mai, Le Thi Quynh ^c   Lien, Vu T K ^c   Hang, Nguyen L K ^c   Wang, Lili ^a   Lee, Laurel Y H ^a   Simmons, Cameron P ^b   McMichael, Andrew J ^a   Farrar, Jeremy J ^b   Askonas, Brigitte A ^a   Duong, Tran Nhu ^c   Thai, Pham Quang ^c   Yen, Nguyen Thi Thu ^c   Rowland Jones, Sarah L ^a   Hien, Nguyen Tran ^c   Horby, Peter ^b   Dong, Tao ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^c NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INFLUENZA VIRUS HEMAGGLUTININ; INFLUENZA VIRUS HEMAGGLUTININ H1; INFLUENZA VIRUS HEMAGGLUTININ H3; INFLUENZA VIRUS HEMAGGLUTININ H5; NEURAMINIDASE N1; NEURAMINIDASE N2; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS SIALIDASE;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; ASYMPTOMATIC INFECTION; CELLULAR IMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC TEST; DISEASE SEVERITY; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; HEMAGGLUTINATION INHIBITION TEST; HIGH RISK POPULATION; HUMAN; HUMAN CELL; INFLUENZA A (H5N1); INFLUENZA VIRUS A H3N2; INTERFERON GAMMA RELEASE ASSAY; MAJOR CLINICAL STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VIET NAM;

ANTIBODIES, VIRAL; ASYMPTOMATIC INFECTIONS; COHORT STUDIES; ENZYME-LINKED IMMUNOSPOT ASSAY; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; SEROEPIDEMIOLOGIC STUDIES; T-LYMPHOCYTES; VIETNAM;

EID: 84555195647     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir689     Document Type: Article

References (34)

1. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353:1374-85. (Pubitemid 41362705)
2. Gambotto A, Barratt-Boyes SM, de Jong MD, Neumann G, Kawaoka Y. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008; 371:1464-75. (Pubitemid 351618340)
3. World Health Organization. Confirmed human cases of avian influenza A(H5N1). Avian InfluenzaWeekly Update 302. 14 October 2011. http://www.who.int/ influenza/human-animal-interface/H5N1-cumulative-table-archives/en/index.html. Accessed 8 April 2011.
4. Salomon R, Webster RG. The influenza virus enigma. Cell 2009; 136:402-10.
5. Buchy P, Vong S, Chu S, et al. Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus. PLoS One 2010; 5:e10864.
6. Vong S, Ly S, Van Kerkhove MD, et al. Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus-Cambodia, 2006. J Infect Dis 2009; 199:1744-52.
7. Schultsz C, Nguyen VD, Hai le T, et al. Prevalence of antibodies against avian influenza A (H5N1) virus among cullers and poultry workers in Ho Chi Minh City, 2005. PLoS One 2009; 4:e7948.
8. Katz JM, Lim W, Bridges CB, et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis 1999; 180:1763-70.
9. Ceyhan M, Yildirim I, Ferraris O, et al. Serosurveillance study on transmission of H5N1 virus during a 2006 avian influenza epidemic. Epidemiol Infect 2010; 138:1274-80.
10. Barr IG, McCauley J, Cox N, et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine 2009; 28:1156-67.
11. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003; 362:1733-45. (Pubitemid 37468326)
12. Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody to avian influenza A (H5N1) virus in human serumby using a combination of serologic assays. J Clin Microbiol 1999; 37:937-43. (Pubitemid 29140593)
13. Temperton NJ, Hoschler K, Major D, et al. A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respi Viruses 2007; 1:105-12.
14. Garcia JM, Pepin S, Lagarde N, et al. Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin. PLoS One 2009; 4:e7918.
15. McElhaney JE, Xie D, Hager WD, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006; 176: 6333-9.
16. Hammitt LL, Bartlett JP, Li S, et al. Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine. Vaccine 2009; 27:7359-66.
17. Zinckgraf JW, SposatoM, Zielinski V, Powell D, Treanor JJ, von Hofe E. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination. Vaccine 2009; 27: 5393-401.
18. Jameson J, Cruz J, Terajima M, Ennis FA. Human CD81 and CD41 T lymphocyte memory to influenza A viruses of swine and avian species. J Immunol 1999; 162:7578-83. (Pubitemid 29277740)
19. Lee LY, Ha DL, Simmons C, et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 2008; 118:3478-90.
20. Kreijtz JH, de Mutsert G, van Baalen CA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 2008; 82:5161-6. (Pubitemid 351705225)
21. Babon JA, Cruz J, Orphin L, et al. Genome-wide screening of human T-cell epitopes in influenza A virus reveals a broad spectrum of CD41 T-cell responses to internal proteins, hemagglutinins, and neuraminidases. Hum Immunol 2009; 70:711-21.
22. Vuola JM, Keating S, Webster DP, et al. Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers. J Immunol 2005; 174:449-55. (Pubitemid 40007434)
23. Todryk SM, Pathan AA, Keating S, et al. The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming. Immunology 2009; 128:83-91.
24. Dong T, Stewart-Jones G, Chen N, et al. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med 2004; 200:1547-7.
25. Nguyen HT, Dharan NJ, Le MT, et al. National influenza surveillance in Vietnam, 2006-2007. Vaccine 2009; 28:398-402.
26. Yang J, Gebe JA, Huston L, et al. H5N1 strain-specific hemagglutinin CD41 T cell epitopes restricted by HLA DR4. Vaccine 2009; 27:3862-9.
27. Kitphati R, Pooruk P, Lerdsamran H, et al. Kinetics and longevity of antibody response to influenza A H5N1 virus infection in humans. Clin Vaccine Immunol 2009; 16:978-81.
28. McMichael AJ, Gotch FM, Dongworth DW, Clark A, Potter CW. Declining T-cell immunity to influenza, 1977-82. Lancet 1983; 2:762-4. (Pubitemid 13003945)
29. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12:1203-7. (Pubitemid 44527358)
30. Crowe BA, Bruhl P, Gerencer M, et al. Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans. Vaccine 2011; 29:166-73.
31. Mbawuike IN, Piedra PA, Cate TR, Couch RB. Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine. J Med Virol 1996; 50:105-11. (Pubitemid 26379294)
32. Octaviani CP, Ozawa M, Yamada S, Goto H, Kawaoka Y. High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol 2010; 84:10918-22.
33. Webster RG, Askonas BA. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur J Immunol 1980; 10:396-401. (Pubitemid 10062920)
34. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006; 440:435-6.